Cardiologia; Insuficiência Cardíaca; American Heart Association; Insuficiência Cardíaca/tratamento farmacológico; Insuficiência Cardíaca/terapia; Humanos; Relatório de Pesquisa; Estados Unidos

ACC/AHA Clinical Practice Guidelines; ACE inhibitors; SGLT2 inhibitors; acute decompensated heart failure; angiotensin and neprilysin receptor antagonist; angiotensin receptor antagonist; atrial fibrillation; beta blockers; cardiac amyloidosis; cardiac failure; cardio-oncology; cardiogenic shock; cardiomyopathy; cardiomyopathy in pregnancy; chronic heart failure; congestive heart failure; diabetes; guideline-directed medical therapy; heart failure; heart failure rehabilitation; heart failure with mildly reduced ejection fraction; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; mineralocorticoid receptor antagonists; mitral regurgitation; palliative care; reduced ejection fraction; right heart pressure; sacubitril-valsartan; social determinants of health; sodium glucose co-transporter 2; systolic heart failure; valvular heart disease